IP Strategy for Entering Brazil: A Market-Entry Guide

Brazil is a first-to-file jurisdiction, so secure trade marks early, either nationally through the Brazilian INPI or via the Madrid Protocol, which Brazil joined in 2019. Expect meaningful patent examination timelines, consider acceleration options, and remember that pharmaceutical patents require ANVISA prior consent.

Brazil is the largest market in Latin America and, for many businesses, the anchor of any regional strategy. It is also a jurisdiction where intellectual property missteps are expensive to unwind, so the sensible order of operations is to settle your IP position before you commit to distribution, hire locally, or spend on brand launch. This guide sketches the strategic terrain for a decision-maker planning entry. It is general orientation, not legal advice, and the specifics should always be confirmed with the Brazilian jurisdiction hub, the Brazilian INPI (the National Institute of Industrial Property), or qualified local counsel.

First-to-file: why timing dominates

The single most important structural fact about Brazil is that it is a first-to-file country for trade marks. Rights generally flow to whoever files first rather than to whoever used the mark first in commerce. Narrow exceptions exist, for marks that are well known in Brazil and for certain good-faith prior use within Brazil, but prior use abroad on its own does not secure the mark. For a foreign business that has traded under a name for years in its home market, this is a trap: a local party (sometimes an opportunistic filer, sometimes a would-be distributor) can register your brand before you do. Recovering a hijacked mark is possible but slow, uncertain, and costly, which is precisely why the strategy is to file early rather than to litigate later.

The practical takeaway is to treat trade mark filing as one of the first acts of market entry, ideally before public announcements, trade-show appearances, or distributor conversations that telegraph your intentions. Our Brazil trade marks overview walks through the mechanics in more detail. Choosing which classes and marks to prioritise, and in which order, is a judgement call that rewards local input.

The Madrid route since 2019

Brazil joined the Madrid Protocol in 2019 and, as part of implementing Madrid, INPI moved to allow multi-class filing, so that a single application can now cover several classes of goods and services rather than forcing a separate filing per class. This capability was rolled out in phases rather than switched on at the moment of accession, so the mechanics and their current availability should be confirmed with the Brazilian INPI or local counsel. For a business entering multiple markets at once, the Madrid Protocol can be an efficient way to extend a home application or registration into Brazil alongside other member countries through one international application.

Madrid is not automatically the right answer for every applicant. A national filing directly with the Brazilian INPI is sometimes preferable, for example where the home (base) application is itself unsettled, since an international registration depends on that base for an initial period. Deciding between the Madrid route and a direct national filing, and sequencing Brazil within a wider portfolio, is exactly the kind of question addressed in choosing which countries to file in. The right structure depends on your base registration, your target markets, and your budget.

The patent backlog and acceleration options

On the patent side, the strategic reality to plan around is timing. Brazil has historically carried a significant patent examination backlog, and while the office has invested in measures to reduce it, a business should assume that examination can take a considerable period rather than counting on a quick grant. Build that into commercial planning: the gap between filing and grant affects when you can enforce, license, or raise on the strength of a granted right.

Several mechanisms exist to accelerate examination in appropriate cases, for instance priority tracks tied to applicant circumstances, the technology field, or reciprocal work-sharing arrangements with other patent offices. Eligibility and the current list of available programmes change over time, so confirm what applies to your case with the Brazil patents overview as a starting point and with local counsel for the live position. The decision to accelerate is a cost-and-timing trade-off rather than a default, and it is worth taking advice on whether your filing qualifies. Official fees apply throughout; confirm the current amounts with the Brazilian INPI (the National Institute of Industrial Property) or local counsel, and treat any timeframe you read as indicative rather than fixed.

Businesses in the life-sciences sector face an additional Brazilian feature: pharmaceutical patent applications require the prior consent of ANVISA (Agencia Nacional de Vigilancia Sanitaria), the national health surveillance agency, as part of the process. This adds a further review stage alongside ordinary patent examination and can influence both timelines and the path an application takes. ANVISA's role here is defined and limited by regulation, focused principally on public-health considerations, rather than a second patentability examination; confirm the current scope with the Brazilian INPI, ANVISA, or local counsel. If your entry involves pharmaceutical products, this is not a detail to discover late. Our dedicated explainer on ANVISA prior consent sets out how this interacts with the wider patent process. The exact scope and procedure have evolved over time, so verify the current position before relying on any particular sequence.

Putting the pieces together

A workable Brazil entry plan usually starts with clearing and filing the core trade marks quickly, given first-to-file exposure, then layers in patent strategy with realistic timelines and a deliberate view on whether acceleration is worth pursuing, and adds the ANVISA dimension where pharmaceuticals are involved. Each of these is a decision under local rules that reward specialist input, and the cost of getting the sequencing wrong is far higher than the cost of advice.

IPEnvoy is not a law firm and does not provide legal advice; this is general information. Confirm the current position with the Brazilian INPI (the National Institute of Industrial Property)'s official website and a qualified local IP professional. Where a business wants that local expertise arranged, IPEnvoy can help connect you with vetted IP specialists in Brazil to pressure-test your entry strategy and handle the filings, so the groundwork is done properly from the outset.

Related

Author: Steffen Hoyemsvoll

Reviewers: pending review